In addition to these two genes, the proteins SREBP2, TREM2, LRP1, and the CYP46A1 gene are all additional candidates as targets to combat Alzheimer’s disease due to their involvement in the metabolic pathway of cholesterol in the brain [27,28,29,30]. Here, SREBF2 is linked to early-onset autosomal dominant Alzheimer disease.